158 related articles for article (PubMed ID: 9990370)
1. Serum concentrations of vascular endothelial growth factor in collagen diseases.
Kikuchi K; Kubo M; Kadono T; Yazawa N; IHN H; Tamaki K
Br J Dermatol; 1998 Dec; 139(6):1049-51. PubMed ID: 9990370
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor in patients with rheumatoid arthritis.
Harada M; Mitsuyama K; Yoshida H; Sakisaka S; Taniguchi E; Kawaguchi T; Ariyoshi M; Saiki T; Sakamoto M; Nagata K; Sata M; Matsuo K; Tanikawa K
Scand J Rheumatol; 1998; 27(5):377-80. PubMed ID: 9808403
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
4. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein D (SP-D) and systemic scleroderma (SSc).
Maeda M; Ichiki Y; Aoyama Y; Kitajima Y
J Dermatol; 2001 Sep; 28(9):467-74. PubMed ID: 11603386
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of basic fibroblast growth factor in collagen diseases.
Kadono T; Kikuchi K; Kubo M; Fujimoto M; Tamaki K
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):392-7. PubMed ID: 8784275
[TBL] [Abstract][Full Text] [Related]
7. Large macrophage colony-forming cells identical to high proliferative potential colony-forming cells in peripheral blood of patients with collagen vascular diseases: high occurrence among patients with systemic sclerosis and dermatomyositis.
Horie S; Minota S; Kano S
J Rheumatol; 2000 Oct; 27(10):2378-81. PubMed ID: 11036833
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.
Yin L; Ge Y; Yang H; Peng Q; Lu X; Zhang Y; Wang G
Clin Rheumatol; 2016 Nov; 35(11):2715-2721. PubMed ID: 27502600
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
10. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.
Lee SS; Joo YS; Kim WU; Min DJ; Min JK; Park SH; Cho CS; Kim HY
Clin Exp Rheumatol; 2001; 19(3):321-4. PubMed ID: 11407088
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
[TBL] [Abstract][Full Text] [Related]
13. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Sato S; Nagaoka T; Hasegawa M; Tamatani T; Nakanishi T; Takigawa M; Takehara K
J Rheumatol; 2000 Jan; 27(1):149-54. PubMed ID: 10648031
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity.
Sone H; Sakauchi M; Takahashi A; Suzuki H; Inoue N; Iida K; Shimano H; Toyoshima H; Kawakami Y; Okuda Y; Matsuo K; Yamada N
Life Sci; 2001 Sep; 69(16):1861-9. PubMed ID: 11693266
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
[TBL] [Abstract][Full Text] [Related]
17. Serum CCL23 levels are increased in patients with systemic sclerosis.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Asano Y; Kadono T; Sato S
Arch Dermatol Res; 2011 Jan; 303(1):29-34. PubMed ID: 20824279
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
[TBL] [Abstract][Full Text] [Related]
19. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn.
Grad S; Ertel W; Keel M; Infanger M; Vonderschmitt DJ; Maly FE
Clin Chem Lab Med; 1998 Jun; 36(6):379-83. PubMed ID: 9711425
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum lymphotactin levels in patients with systemic sclerosis.
Muroi E; Ogawa F; Shimizu K; Komura K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2008 May; 35(5):834-8. PubMed ID: 18322986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
